NEPH

AS OF

Nov 14 closing price

Price

$1.58

Change

-$0.00 (-0.00%)

Capitalization

23.09M

103 days until earnings call

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

NEPH Stock NEPH is expected to report earnings to rise+33% to -4 cents per share on May 20

GET DAILY SIGNALS

Get AI intraday signals

A.I.dvisor
at Tickeron.com

Buy or Sell

View Daily Signals

05/19/24

NEPH - Nephros

Q1'24

Est.

$-0.04

Q4'23

Missed

by $0.03

Q3'23

Beat

by $0.05

Q2'23

Beat

by $0.02

Q1'23

Beat

by $0.05

The last earnings report on December 31 showed earnings per share of -6 cents, missing the estimate of -3 cents. P/B Ratio (2.775) is normal, around the industry mean (22.537). P/E Ratio (0.000) is within average values for comparable stocks, (82.402). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.589). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.605) is also within normal values, averaging (51.817). With 60.17K shares outstanding, the current market capitalization sits at 23.09M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system

Industry MedicalSpecialties

Profile

Fundamentals

Details

Industry

N/A

Address

380 Lackawanna Place

Phone

+1 201 343-5202

Employees

Web

https://www.nephros.com